Stephen Colagiuri Named New Editor-In-Chief
Diabetes Research and Clinical Practice
Oxford, UK, 10 April 2008 - Stephen Colagiuri has been named the new Editor-in-Chief of Diabetes Research and Clinical Practice, effective April 1, 2008. Professor Colagiuri takes over from Professor Nigishi Hotta who has been acting as Editor-in-Chief since 2004 and now becomes an Honorary Editor-in-Chief of Diabetes Research and Clinical Practice, the official journal of the International Diabetes Federation/Western Pacific Region.
“It is an honor to take on this role and I look forward to the challenge and to building on the excellent work of Professor Hotta”, commented Professor Colagiuri.
Stephen Colagiuri is Professor of Metabolic Health at the University of Sydney. His research interests focus on development and implementation of evidence-based guidelines, cardiometabolic risk assessment, diabetes screening and prevention, the glycemic index, and economic aspects of diabetes and obesity. He has over 100 publications in scientific journals and books, and is a past President of the Australian Diabetes Society.
He is also a member of the Diabetes Expert Advisory Committee of the Commonwealth Department of Health and Aged Care, chair of the International Diabetes Federation Global Guideline Working Group, and an advisor on diabetes to the World Health Organization.
# # #
About Diabetes Research and Clinical Practice
Diabetes Research and Clinical Practice is devoted to covering original research articles and high-quality reviews in areas of growing interest in the field of epidemiology, experimental biology, nutrition and clinical practice. The purpose of the journal is to encourage interdisciplinary discussion of topics which are relevant to the fields of diabetology and medical science on an international scale, with a particular focus on those that are or will be clinically relevant.
Diabetes Research and Clinical Practice is the official journal of the International Diabetes Federation, Western Pacific Region.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+44 1865 843786